These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6223461)

  • 1. [The role of histidine-rich glycoprotein in the regulation mechanism of fibrinolysis in humans].
    Lijnen HR
    Verh K Acad Geneeskd Belg; 1982; 44(5-6):307-29. PubMed ID: 6223461
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D; Lijnen HR
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of plasminogen activators and inhibitors with plasminogen and fibrin.
    Lijnen HR; Collen D
    Semin Thromb Hemost; 1982 Jan; 8(1):2-10. PubMed ID: 6460318
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization and antithrombotic action of tissue plasminogen activator.
    Bergqvist D; Nilsson IM; Pandolfi M
    Experientia; 1984 Jan; 40(1):67-8. PubMed ID: 6229416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathophysiological role of fibrinolysis inhibitors.
    Lijnen HR; Collen D
    Ric Clin Lab; 1984; 14(3):499-505. PubMed ID: 6084295
    [No Abstract]   [Full Text] [Related]  

  • 6. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.
    Collen D
    Thromb Haemost; 1980 Jun; 43(2):77-89. PubMed ID: 6450468
    [No Abstract]   [Full Text] [Related]  

  • 7. Histidine-rich glycoprotein and alpha 2-plasmin inhibitor in inhibition of plasminogen binding to fibrin.
    Ichinose A; Mimuro J; Koide T; Aoki N
    Thromb Res; 1984 Feb; 33(4):401-7. PubMed ID: 6710439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of plasminogen binding site of alpha 2-plasmin inhibitor on the initiation and regulation of fibrinolysis].
    Iwamoto M; Sugiyama N
    Rinsho Byori; 1989 Apr; Spec No 81():118-25. PubMed ID: 2526883
    [No Abstract]   [Full Text] [Related]  

  • 9. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical aspects of the streptokinase effect].
    Landmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):437-44. PubMed ID: 63431
    [No Abstract]   [Full Text] [Related]  

  • 11. The fibrinolytic system and its relation to inflammatory diseases.
    Clemmensen I; Andersen RB
    Semin Arthritis Rheum; 1982 May; 11(4):390-8. PubMed ID: 6179164
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tissue type plasminogen activator and its inhibition in blood of patients operated on for prostatic carcinoma].
    Iwan-Zietek I; Zietek Z; Kotschy M; Rość D; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):91-3. PubMed ID: 8756741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural inhibitors of fibrinolysis.
    Collen D
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():24-30. PubMed ID: 6448870
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intensification of the effect of exogenous plasminogen activators on lysis of fibrin blood clots due to a decrease in the level of alpha-2- antiplasmin by a plasmasorption method].
    Ogloblina OG; Saburova OS; Semenova OA; Belova LA
    Biokhimiia; 1994 Jan; 59(1):62-8. PubMed ID: 7509643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The regulation of fibrinolysis].
    Matsuo O
    Nihon Rinsho; 1989 Apr; 47(4):739-45. PubMed ID: 2526261
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
    Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
    Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism of fibrinolysis--a system involved with malignant cells.
    Cederholm-Williams SA
    Invasion Metastasis; 1981; 1(2):85-98. PubMed ID: 6234253
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of para-aminobenzoic acid on the fibrinolytic activity of blood].
    Andreenko GV; Karabasova MA; Liutova LV; Podorol'skaia LV; Serebriakova TN; Sologub AA; Akberova SI; Stroeva OG
    Dokl Akad Nauk; 1996 Jan; 346(2):268-70. PubMed ID: 8640127
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.